This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Decentralized Clinical Trials
Hybrid Event | June 6 - 8, 2022
In-Person Event: June 6 - 8, Hyatt Regency Coral Gables, Miami, FloridaDigital Experience: Live-streamed keynotes on June 6 - 8 + 10 days on-demand access to all presentation recordings from June 14th

Shelby Stillwagon
Senior Director, Decentralized Clinical Trials at ProPharma Group, USA


Shelby Stillwagon is Senior Director of Decentralized Clinical Trials at ProPharma Group. She started her career in academic research then moved to the clinical site environment working in oncology and has spent the past 8 years focused on supporting and operationalizing Decentralized Clinical Trials. Since 2013, Shelby has worked with numerous sponsors across hundreds of clinical trials where she’s provided expert guidance on decentralized visit design and logistics. She has held multiple oversight roles, supporting global teams across a wide variety of therapeutic areas including rare disease, pediatrics, oncology, neurology, and infectious disease. Her expertise is in collaborating with involved stakeholders (Sponsor, CRO, vendors, etc.) to build and maintain study-specific, quality-focused processes that support complex decentralized clinical trials. 

Agenda Sessions

  • To Decentralize or not to Decentralize, that is the Question